Matthew Hardwick

941 total citations
16 papers, 770 citations indexed

About

Matthew Hardwick is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Matthew Hardwick has authored 16 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Matthew Hardwick's work include Neuroscience and Neuropharmacology Research (6 papers), Estrogen and related hormone effects (4 papers) and Receptor Mechanisms and Signaling (3 papers). Matthew Hardwick is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Estrogen and related hormone effects (4 papers) and Receptor Mechanisms and Signaling (3 papers). Matthew Hardwick collaborates with scholars based in United States, United Kingdom and France. Matthew Hardwick's co-authors include Vassilios Papadopoulos, Martine Culty, Katy Drieu, Hakima Amri, Branislav Vidić, Caterina Cascio, N. Boujrad, Hua Li, J.M. Bernassau and Martine Garnier and has published in prestigious journals such as Biochemistry, ACS Applied Materials & Interfaces and Journal of Clinical Microbiology.

In The Last Decade

Matthew Hardwick

15 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Hardwick United States 11 374 224 121 79 72 16 770
Tatsunori Suzuki Japan 18 429 1.1× 136 0.6× 95 0.8× 113 1.4× 96 1.3× 31 979
Lan N. Tu United States 14 424 1.1× 122 0.5× 108 0.9× 92 1.2× 117 1.6× 35 771
Antonella La Russa Italy 17 251 0.7× 172 0.8× 63 0.5× 33 0.4× 119 1.7× 46 817
Yuting Tang China 15 509 1.4× 188 0.8× 58 0.5× 27 0.3× 70 1.0× 55 814
A C Papp United States 15 464 1.2× 117 0.5× 70 0.6× 31 0.4× 86 1.2× 29 986
Yasuhiro Yoshioka Japan 20 385 1.0× 226 1.0× 77 0.6× 103 1.3× 93 1.3× 47 1.0k
Sookja Kim Chung Hong Kong 14 400 1.1× 141 0.6× 33 0.3× 70 0.9× 114 1.6× 22 739
Toshihito Nagata Japan 16 428 1.1× 74 0.3× 119 1.0× 41 0.5× 43 0.6× 34 709
Masato Nagahama Japan 17 258 0.7× 177 0.8× 100 0.8× 25 0.3× 83 1.2× 40 685
Yoshinori Takei Japan 17 564 1.5× 88 0.4× 98 0.8× 41 0.5× 89 1.2× 50 878

Countries citing papers authored by Matthew Hardwick

Since Specialization
Citations

This map shows the geographic impact of Matthew Hardwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Hardwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Hardwick more than expected).

Fields of papers citing papers by Matthew Hardwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Hardwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Hardwick. The network helps show where Matthew Hardwick may publish in the future.

Co-authorship network of co-authors of Matthew Hardwick

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Hardwick. A scholar is included among the top collaborators of Matthew Hardwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Hardwick. Matthew Hardwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tracy, Sharon L., et al.. (2022). Virus inactivation on common indoor contract fabrics. Indoor and Built Environment. 31(5). 1381–1392. 1 indexed citations
2.
Nilsson-Payant, Benjamin E., et al.. (2021). Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus. ACS Applied Materials & Interfaces. 13(26). 30317–30325. 41 indexed citations
3.
Benda, Natalie C., et al.. (2014). Reducing healthcare-associated infections in an ambulatory dialysis unit: Identification and alignment of work system factors. American Journal of Infection Control. 42(10). S284–S290. 6 indexed citations
4.
Kłubo-Gwieździńska, Joanna, Kirk Jensen, Andrew J. Bauer, et al.. (2012). The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress. Journal of Endocrinology. 214(2). 207–216. 17 indexed citations
5.
Acuña-Villaorduña, Carlos, et al.. (2010). Evaluation of mupA Evigene in Comparison to Disk Diffusion for Detection of High-Level Mupirocin Resistance in Clinical Isolates of Staphylococcus aureus. Journal of Clinical Microbiology. 48(8). 2953–2954. 1 indexed citations
6.
Pyrgos, Vasilios, Tin Sein, Margaret P. Cotton, et al.. (2009). Effects of Immunomodulatory and Organism-Associated Molecules on the Permeability of anIn VitroBlood-Brain Barrier Model to Amphotericin B and Fluconazole. Antimicrobial Agents and Chemotherapy. 54(3). 1305–1310. 15 indexed citations
7.
8.
Li, Wenping, Matthew Hardwick, Dean S. Rosenthal, Martine Culty, & Vassilios Papadopoulos. (2006). Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Biochemical Pharmacology. 73(4). 491–503. 36 indexed citations
9.
Hardwick, Matthew, Ming‐Kai Chen, Kwamena E. Baidoo, Martin G. Pomper, & Tomás R. Guilarte. (2005). In Vivo Imaging of Peripheral Benzodiazepine Receptors in Mouse Lungs: A Biomarker of Inflammation. Molecular Imaging. 4(4). 432–8. 31 indexed citations
10.
Delavoie, Franck, Hua Li, Matthew Hardwick, et al.. (2003). In Vivo and in Vitro Peripheral-Type Benzodiazepine Receptor Polymerization:  Functional Significance in Drug Ligand and Cholesterol Binding. Biochemistry. 42(15). 4506–4519. 148 indexed citations
11.
Hardwick, Matthew, et al.. (2002). Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cells. Cancer Genetics and Cytogenetics. 139(1). 48–51. 32 indexed citations
12.
Hardwick, Matthew, Janice D. Rone, Zeqiu Han, Bassem R. Haddad, & Vassilios Papadopoulos. (2001). Peripheral-type benzodiazepine receptor levels correlate with the ability of human breast cancer MDA-MB-231 cell line to grow in scid mice. International Journal of Cancer. 94(3). 322–327. 38 indexed citations
13.
Papadopoulos, Vassilios, Hua Li, Hakima Amri, et al.. (2000). Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells.. PubMed. 20(5A). 2835–47. 50 indexed citations
14.
Papadopoulos, Vassilios, Hakima Amri, N. Boujrad, et al.. (1997). Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids. 62(1). 21–28. 324 indexed citations
15.
Hardwick, Matthew & P. Hutton. (1990). Capnography: Fundamentals of current clinical practice. Current Anaesthesia and Critical Care. 1(3). 176–180. 2 indexed citations
16.
Atkinson, Stephanie A., Matthew Hardwick, & P. Kendall‐Taylor. (1988). Thyrotrophin-blocking antibodies in goitrous primary hypothyroidism: detection by a highly sensitive bioassay and determination of site of action. Journal of Endocrinology. 118(1). 141–147. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026